Fingerprint
Dive into the research topics of 'A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas
Yazmin Odia, Fabio M. Iwamoto, Argirios Moustakas, Tyler J. Fraum, Carlos A. Salgado, Aiguo Li, Teri N. Kreisl, Joohee Sul, John A. Butman, Howard A. Fine
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations